FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

926312002: Pralsetinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4042885019 Pralsetinib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4042886018 Pralsetinib en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pralsetinib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Pralsetinib Is a Pyridine true Inferred relationship Existential restriction modifier
Pralsetinib Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Pralsetinib Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Pralsetinib Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pralsetinib Has active ingredient True Pralsetinib Inferred relationship Existential restriction modifier 1
Product containing pralsetinib (medicinal product) Has active ingredient True Pralsetinib Inferred relationship Existential restriction modifier 1
Product containing pralsetinib in oral dose form (medicinal product form) Has active ingredient True Pralsetinib Inferred relationship Existential restriction modifier 1
Product containing only pralsetinib in oral dose form (medicinal product form) Has active ingredient True Pralsetinib Inferred relationship Existential restriction modifier 1
Product containing precisely pralsetinib 100 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Pralsetinib Inferred relationship Existential restriction modifier 1
Product containing precisely pralsetinib 100 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance True Pralsetinib Inferred relationship Existential restriction modifier 1
Gavreto 100mg capsules (Roche Products Ltd) 120 capsule Has specific active ingredient True Pralsetinib Inferred relationship Existential restriction modifier
Gavreto 100mg capsules (Roche Products Ltd) Has specific active ingredient True Pralsetinib Inferred relationship Existential restriction modifier
Gavreto 100mg capsules (Roche Products Ltd) 60 capsule Has specific active ingredient True Pralsetinib Inferred relationship Existential restriction modifier
Pralsetinib 100mg capsules 120 capsule Has specific active ingredient True Pralsetinib Inferred relationship Existential restriction modifier
Pralsetinib 100mg capsules Has specific active ingredient True Pralsetinib Inferred relationship Existential restriction modifier
Pralsetinib 100mg capsules 60 capsule Has specific active ingredient True Pralsetinib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start